Evidence map›Paper›PMID 30316868›Full record

ArticleEBioMedicine2018

Improved assays to measure and characterize the inducible HIV reservoir.

Marta Massanella, Christina Yek, Steven M Lada, Masato Nakazawa, Neda Shefa, Karissa Huang, Douglas D Richman

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. IBA-1Research square · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. HIV Reservoir: How to Measure It?Current HIV/AIDS reports · 2023
    Review
  8. Review
  9. How CD4Biomedicines · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. The reservoir of latent HIV.Frontiers in cellular and infection microbiology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marta MassanellaUniversity of California San Diego, La Jolla, CA, USA.
Christina YekUniversity of California San Diego, La Jolla, CA, USA.
Steven M LadaUniversity of California San Diego, La Jolla, CA, USA.
Masato NakazawaUniversity of California San Diego, La Jolla, CA, USA.
Neda ShefaUniversity of California San Diego, La Jolla, CA, USA.
Karissa HuangUniversity of California San Diego, La Jolla, CA, USA.
Douglas D RichmanUniversity of California San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA. Electronic address: drichman@ucsd.edu.
University of California San Diego · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J, RILEY, JAMES L. · 2016 to 2021
$24.5M
Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI126619 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2016 to 2020
$23.2M
NIAID NIH HHS P30 AI036214NIAID NIH HHS UM1 AI126619NIAID NIH HHS UM1 AI126620
6 · The paper itself

Abstract

backgroundImproved assays are critical to better characterize the HIV reservoir and to reliably evaluate candidate intervention strategies. Here we describe different methods to quantify the HIV reservoir.

methodsWe developed an optimized quantitative viral outgrowth assay (QVOA) to quantify the frequency of cells harboring replication-competent HIV, which is simpler and more sensitive than classical QVOAs. We also developed new inducible RNA assays that concomitantly measure the frequency of cell-associated [ca-] (gag and tat-rev) and cell-free [cf-] HIV RNA after three days of anti-CD3/CD28 stimulation.

findingsThe median frequency of the infected cells measured after induction was 94 IQR[60-132], 16 IQR [9-29] and 2.9 IQR[1.9-6.8] cells/10

interpretationThese inducible RNA assays provide more sensitivity and a greater dynamic range for the monitoring of reduction of the reservoir by eradication strategies. Such assays may serve as robust and useful tools for clinical investigations of the HIV reservoir.

Indexed as

Viral LoadAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCD4-Positive T-LymphocytesFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedProvirusesRNA, ViralVirus ActivationVirus LatencyVirus ReplicationRNA, ViralEradicationHIV reservoirInducible HIV RNALatencyVOA

Identifiers

PMID30316868
PMCPMC6197429
OpenAlexW2895792705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.